Pharmalot... Pharmalittle... Good Morning

Hello, everyone, and how are you today? A bright shiny sun is warming the otherwise chilly Pharmalot corporate campus, where the leaves continue to fall, the official mascots are greeting passersby and the short people are hustling off, as always, to their houses of learning. As for us we are in the midst of our usual routine which, of course, includes brewing a cup or two of stimulation. Feel free to do the same. Meanwhile, here are some tidbits to get the day started. Hope yours goes well and you conquer the world. But do stay in touch... J&J Told To Pay $11M For Birth Defects Caused By Topamax (Bloomberg News) Long-Term Use Of Oral Contraceptives Raises Glaucoma Risk (NY Daily News) India Considers Regs To Tighten Foreign Investment In Pharma (Economic Times) EU Approves Bayer Prostate Cancer Drug (PM Live) Vitamin Maker DSM To Spin Off Pharmaceutical Unit (Financial Times) Cegedim Launches A Social Network For Doctors (PharmaLive) Amgen Says Melanoma Drug Improved Survival (Associated Press) Merck Anti-PD-1 Drug Shows Survival...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs